Abstract
Acetyl-L-carnitine (ALC), a naturally occurring endogenous compound, has been shown to improve the cognitive performance of patients with senile dementia Alzheimer’s type, and to be involved in cholinergic neurotransmission. Because ALC is an endogenous compound, validation of the analytical methods of ALC in the biological fluids is very important and difficult. This study was presented validation and correction for plasma ALC concentrations and pharmacokinetics after oral administration of ALC to human volunteers. ALC concentrations in human plasma were corrected by subtracting the concentration of blank plasma from each sample. Precision and accuracy (bias %) for uncorrected ALC concentrations were below 2.6 and 6.5% for intra-days, and 4.0 and 9.4% for inter-days, respectively. Precision and accuracy (bias %) for corrected ALC concentrations were below 10.9 and 6.0% for intra-days, and 10.5 and 16.9% for inter-days, respectively. Quantitation limit was 0.1 ¼g/mL. After oral administration of a 500 mg ALC tablet to 8 healthy volunteers, the principle pharmacokinetic parameters were 4.2 h of the half-life (t1/2,β), the area under the curve (AUC0→8) of 9.88 ¼gh/mL, and 3.1 h of the time (Tmax) to reach Cmax. This study first describes the pharmacokinetic study after oral administration of a single dose of ALC in human volunteers.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Referencees
Breme, Carnitine-metabolism and functions.Pharmacol. Rev., 63, 1420–1480 (1983).
Cugini, P., Danese, C., Colotto, M., Arceri, D., Angrisani, L., Colosi, L., and De Rosa, R., Circardian rhythm of serum levo-carnitine: parameters.Clin. Ther., 153, 237–242 (2002).
Evans, A. M., Faull, R., Fornasini, G., Lemanowicz, E. F., Longo, A., Pace, S., and Nation, R. L., Pharmacokinetics of L-camitine in patients with end-stage renal disease undergoing long-term hemodialysis.Clin. Pharmacol. Ther., 68, 238–249 (2000).
Falchetto, S., Kato, G., and Provini, L., The action of carnitine on cortical neurons.Can. J. Physiol. Pharmacol., 49, 1–7 (1971).
Fritz, I. B. and Arrigoni-Martelli, E., Sites of action of carnitine and its derivatives on the cardiovascular system: interactions with membranes.Trend Pharmacol. Sci., 14, 355–360 (1993).
Fritz, I. B. and Marquis, N. R., The role of acylcarnitine esters and carnitine palmityltransferase in the transport of fatty acyl groups across mitochondrial membranes.Proc. Natl. Acad. Sci. U.S.A., 54, 1226–1233 (1965).
Janiri, L., Falcone, M., Persico, A., and Tempesta, E., Activity of L-carnitine and L-acetylcarnitine on cholinoceptive neocorical neurons of the ratin vivo.J. Neural, transm., 86, 135–146 (1991).
Kagawa, M., Machida, Y., and Nishi, H., Enantiomeric purity determination of acetyl-L-carnitine by reversed-phase high-performance liquid chromatography using chiral derivatization.J. Chromatogr. A., 857, 127–135 (1999).
Kamimori, H., Hamashima, Y., and Konishi, M., Determination of carnitine and saturated-acyl group carnitines in human urine by high-performance liquid chromatography with fluorescence detection.Anal. Biochem., 218, 417–424 (1994).
Kelly, J. G., Hunt, S., Doyle, G. D., Laher, M. S., Carmody, M., Marzo, A., and Arrigoni Martelli, E., Pharmacokinetics of oral acetyl-L-carnitine in renal impairment.Eur. J. Clin. Pharmacol., 38, 309–312 (1990).
Lambert, M. E., Shipley, K., Holbrook, I., Faragher, E. B., and Irving, M. H., Serum carnitine levels in normal individuals.JPENJ. Parenter Enteral Nutr., 12, 143–146 (1988).
Longo, A., Bruno, G., Curti, S., Mancinelli, A., and Miotto, G., Determination of L-carnitin., acetyl-L-carnitine and propionyl-L-carnitine in human plasma by high-performance liquid chromatography after pre-column derivatization with 1-aminoanthracene.J. Chromatogr. B. Biomed. Appl., 686, 129–139 (1996).
Marzo, A., Arrigoni Martelli, E., Urso, R., Rocchetti, M., Rizza, V., and Kelly, J. G., Metaboilsm and disposition of intravenously administered acetyl-L-carnitine in healthy volunteers.Eur. J. Clin. Pharmacol., 37, 59–63 (1989).
Millington, D. S., Norwood, D. L., Kodo, N., Roe, C. R., and Inoue, F., Application of fast atom bombardment with tandem mass spectrometry and liquid chromatography/mass spectrometry to the analysis of acylcarnitines in human urine, bloo., and tissue.Anal. Biochem., 180, 331–339 (1989).
Minkler, P. E. and Hoppel, C. L., Quantitation of free carnitine, individual short-and medium-chain acylcarnitine., and total carnitine in plasma by high-performance liquid chromatography.Anal. Biochem., 212, 510–518 (1993).
Minkler, P. E., Brass, E. P., Hiatt, W. R., Ingalls, S. T., and Hoppel, C. L., Quantitation of carnitine, acetylcarnitine, and total carnitine in tissues by high-performance liquid chromatography: the effect of exercise on carnitine homeostasis in man.Anal. Biochem., 231, 315–322 (1995).
Pace, S., Longo, A., Toon, S., Rolan, P., and Evans, A. M., Pharmacokinetics of propionyl-L-carnitine in humans: evidence for saturable tubular reabsorption.Br. J. Clin. Pharmacol., 50(5), 441–448 (2000).
Parnetti, L., Giati, A., Mecocci, P., Cadini, D., and Sinin, U., Pharmacokinetics of IV and oral acetyl-L-carnitine in a multiple dose regimen in patients with senile dementia of Alzheimer type.Eur. J. Clin. Pharmacol., 42, 89–93 (1992).
Passeri, M., Crucinotta, D. Bonati, P. A., lannuccelli, M., Parnetti, L., and Senin, U., Acetyl-L-carnitine in the treatment of mildly demented elderly patients.Int. J. Clin. Pharmacol. Res., 10, 75–79 (1990).
Passeri, M., lannuccelli, M., Ciotti, G., Bonati, P. A., Nolfe, G., and Crucinotta, D., Mental impairment in aging: selection of patient., methods of evaluation and therapeutic possibilities of acetyl-L-carnitine.Int. J. Clin. Pharmacol. Res., 8, 367–376 (1988).
Piovesan P., Quatrini, G., Pacifici, L., Taglialatela, G., and Angelucci, L., Acetyl-L-carnitine restores choline acetyltransferase activity in the hippocampus of rats with partial unilateral fimbra-fornix transsection.Int. J. Dev. Neurosci., 13, 13–19 (1995).
Poorthuis, B. J., Jille-Vlckova, T., and Onkenhout, W., Determination of acylcarnitines in urine of patients with inborn errors of metabolism using high-performance liquid chromatography after derivatization with 4′-bromphenacylbromide.Clin. Chim. Acta, 216 (1–2), 53–61 (1993).
Rebuzzi, A. G., Schiavoni, G., Lanza, G. A., Amico, C., Natale, A., Lucente M., and Manzoli, U., Rhythm of carnitine levels in serum and urine of normal subjects.Drugs Exp. Clin. Res., 15, 43–46 (1989).
Shargel, L. and Yu, A. B. C., Chapter 9. Pharmacokinetics of drug absorption. InApplied Biopharmacokinetics and Pharmacokinetics, 3rd ed., Appleton & Lange, Nowwalk, USA, 169–192 (1993).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Kwon, OS., Chung, Y.B. Hplc determination and pharmacokinetics of endogenous acetyl-l-carnitine (alc) in human volunteers orally administered a single dose of alc. Arch Pharm Res 27, 676–681 (2004). https://doi.org/10.1007/BF02980169
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF02980169